U. Bissinger et al., INTUBATING CONDITIONS AFTER ATRACURIUM AN D VECURONIUM ADMINISTERED BY BOLUS INJECTION OR THE PRIMING TECHNIQUE, Anasthesist, 45(6), 1996, pp. 512-517
Prompted by the ongoing discussion of the pros and cons of using succi
nylcholine, this study was conducted to compare the responses to bolus
injections of atracurium or vecuronium with those after sequential in
jection of these drugs (priming principle). We evaluated the earliest
possible intubation times, intubating conditions, and the onset times
(i.e. times from the end of injection to the maximum blockade) under c
onditions approaching real use as closely as possible. Methods. The ra
ndomized and double-blind study was carried out with 80 ASA risk class
1 and 2 patients. Approval of the institutional ethics committee was
obtained, and each patient gave informed consent. Patients were random
ly allocated to four study groups of 20 patients each. Isotonic saline
was administered to those patients assigned to the atracurium or vecu
ronium bolus groups, whereas the patients assigned to the other two gr
oups received a priming injection of either atracurium (0.05 mg/kg) or
vecuronium (0.01 mg/kg). We observed the patients for signs of incipi
ent muscular weakness before the induction of anaesthesia. Anaesthesia
was induced with thiopental 3.5 min after the first injection (5 mg/k
g and 50-100 mg before intubation). After a further 1 min during which
adequate mask ventilatin with oxygen was assured, corresponding to a
priming interval of 4.5 min, 0.5 mg/kg of atracurium or 0.1 mg/kg of v
ecuronium was administered to the patients in the bolus groups and 0.4
5 mg/kg of atracurium or 0.09 mg/kg of vecuronium as intubating doses
to those in the priming groups. Intubation was attempted at 90, 120, 1
50 and 180 s thereafter. Intubating conditions were evaluated on the b
asis of laryngoscopy, vocal cord movement and coughing or bucking of t
he patients. Neuromuscular function was monitored via accelerometry at
the adductor pollicis muscle (TOF stimulation of the ulnar nerve ever
y 15 s). Results. The priming doses did not diminish the elicited twit
ches of the adductor pollicis muscle, but led to heavy eyelids and dou
ble vision in 35% of the atracurium patients and 47% of the vecuronium
patients; these symptoms were well tolerated by the patients. At the
time of intubation the adductor pollicis muscle was relaxed to approxi
mately the same degree in all groups (mean+/-SD for the TOF ratios in
the bolus groups was 0.46+/-0.37 for atracurium, 0.45+/-0.4 for vecuro
nium; in the priming groups 0.52+/-0.39 for atracurium, 0.53+/-0.36 fo
r vecuronium). The administration of the relaxants in divided doses si
gnificantly shortened the intubating time after atracurium (100 vs 124
a) and improved the intubating conditions of vecuronium (good vs tole
rable), but had no effect on the time course of the neuromuscular bloc
kade (onset times in the bolus groups 224+/-84 s for atracurium and 20
9+/-64 s for vecuronium; in the priming groups 249+/-112 s for atracur
ium and 205+/-52 s for vecuronium). Conclusions. The priming technique
presented here is clinically superior to the bolus method and therefo
re should be preferred in all elective cases and in those patients in
whom succinylcholine is contraindicated.